drugset / Trial / NCT05952089
A Study to Assess the Effect of Danicamtiv on the Drug Levels of Midazolam in Participants With Stable Heart Failure
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is assess the effect of danicamtiv, as an inducer on the drug levels of midazolam in participants with heart failure with reduced ejection fraction (HFrEF).
Timeline
- Start
- 2023-08-17
- Primary completion
- 2024-03-15
- Completion
- 2024-03-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Danicamtiv | Small molecule | — | — |
| Subject | Midazolam | Small molecule | — | — |